Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07856797
NA

A Study to Confirm Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

Sponsor: Merz North America, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to confirm the long-term safety, effectiveness, and degradation profile of RADIESSE® Injectable Implant for the correction of moderate to severe nasolabial folds (NLFs) in Chinese adults. Eligible participants will receive treatment with RADIESSE® Injectable Implant in both NLFs and may receive an optional touch-up treatment at Month 1 at investigator's discretion. Participants will be followed for up to 24 months after last treatment.

Official title: A Prospective, Open-Label, Multicenter, Post-Market Clinical Follow-Up Study to Confirm the Long-term Safety and Effectiveness of RADIESSE® Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

163

Start Date

2026-10-27

Completion Date

2029-02

Last Updated

2026-10-29

Healthy Volunteers

No

Interventions

DEVICE

Subdermal Implant

Participants will receive treatment with RADIESSE® Injectable Implant.

Locations (8)

Merz Investigative Site

Beijing, China

Merz Investigative Site

Changde, China

Merz Investigative Site

Chengdu, China

Merz Investigative Site

Gaozhou, China

Merz Investigative Site

Hangzhou, China

Merz Investigative Site

Nanjing, China

Merz Investigative Site

Xianyang, China

Merz Investigative Site

Yibin, China